DiaMedica Therapeutics Statistics

Total Valuation

DMAC has a market cap or net worth of $352.94 million. The enterprise value is $301.82 million.

Market Cap	352.94M
Enterprise Value	301.82M

Important Dates

The next estimated earnings date is Tuesday, August 11, 2026, after market close.

Earnings Date	Aug 11, 2026
Ex-Dividend Date	n/a

Share Statistics

DMAC has 53.88 million shares outstanding. The number of shares has increased by 19.44% in one year.

Current Share Class	53.88M
Shares Outstanding	53.88M
Shares Change (YoY)	+19.44%
Shares Change (QoQ)	+2.63%
Owned by Insiders (%)	46.61%
Owned by Institutions (%)	23.81%
Float	28.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.47
P/TBV Ratio	7.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.11, with a Debt / Equity ratio of 0.00.

Current Ratio	9.11
Quick Ratio	8.98
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -86.47% and return on invested capital (ROIC) is -56.19%.

Return on Equity (ROE)	-86.47%
Return on Assets (ROA)	-49.96%
Return on Invested Capital (ROIC)	-56.19%
Return on Capital Employed (ROCE)	-77.61%
Weighted Average Cost of Capital (WACC)	9.73%
Revenue Per Employee	n/a
Profits Per Employee	-$1.00M
Employee Count	35
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, DMAC has paid $29,000 in taxes.

Income Tax	29,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +65.82% in the last 52 weeks. The beta is 1.00, so DMAC's price volatility has been similar to the market average.

Beta (5Y)	1.00
52-Week Price Change	+65.82%
50-Day Moving Average	6.06
200-Day Moving Average	7.16
Relative Strength Index (RSI)	63.83
Average Volume (20 Days)	219,640

Short Selling Information

The latest short interest is 4.86 million, so 9.02% of the outstanding shares have been sold short.

Short Interest	4.86M
Short Previous Month	4.87M
Short % of Shares Out	9.02%
Short % of Float	16.90%
Short Ratio (days to cover)	29.31

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-36.74M
Pretax Income	-35.07M
Net Income	-35.10M
EBITDA	-36.69M
EBIT	-36.74M
Earnings Per Share (EPS)	-$0.71

Full Income Statement

Balance Sheet

The company has $51.33 million in cash and $212,000 in debt, giving a net cash position of $51.12 million or $0.95 per share.

Cash & Cash Equivalents	51.33M
Total Debt	212,000
Net Cash	51.12M
Net Cash Per Share	$0.95
Equity (Book Value)	47.24M
Book Value Per Share	0.88
Working Capital	46.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$31.00 million and capital expenditures -$36,000, giving a free cash flow of -$31.03 million.

Operating Cash Flow	-31.00M
Capital Expenditures	-36,000
Depreciation & Amortization	43,000
Net Borrowing	-10,000
Free Cash Flow	-31.03M
FCF Per Share	-$0.58

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DMAC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.44%
Shareholder Yield	-19.44%
Earnings Yield	-9.95%
FCF Yield	-8.79%

Analyst Forecast

The average price target for DMAC is $15.50, which is 136.64% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.50
Price Target Difference	136.64%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 15, 2018. It was a reverse split with a ratio of 1:20.

Last Split Date	Nov 15, 2018
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2